4017 logo

Dr. Soliman Abdel Kader Fakeeh Hospital Company Stock Price

SASE:4017 Community·ر.س7.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author

4017 Share Price Performance

ر.س34.10
-14.90 (-30.41%)
ر.س34.10
-14.90 (-30.41%)
Price ر.س34.10

4017 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
4 Rewards

Dr. Soliman Abdel Kader Fakeeh Hospital Company Key Details

ر.س3.1b

Revenue

ر.س2.4b

Cost of Revenue

ر.س703.9m

Gross Profit

ر.س413.7m

Other Expenses

ر.س290.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.26
22.78%
9.39%
17.6%
View Full Analysis

About 4017

Founded
1978
Employees
n/a
CEO
Mazen Soliman Abdel Fakeeh
WebsiteView website
dsfhjeddah.fakeeh.care

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. The company operates through Medical Services; Education; and Trading, Retail & Others segments. It provides various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, lasik surgery, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pediatric orthopedic surgery, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery, as well as pain treatment and palliative care services. The company also operates AIRS, anesthesia, burn, diagnostics service, emergency medicine, endoscopy, intensive care, NICU, renal dialysis, rhinoplasty, and institute of robotic surgery facilities; establishes and manages pharmacies; and provides analysis and radiology laboratory, healthcare, medical education, and home health care services. In addition, it engages in the trading of pharmaceutical products, spectacles, and cosmetics; construction and contracting; wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was incorporated in 1978 and is based in Jeddah, the Kingdom of Saudi Arabia.